Get the newest information from the Immunization Program right in your inbox!
Sign up
Trouble logging in? Forgot password? We can help!
215-685-6784
215-238-6944
Complete the online reporting agreement form
Or fill out the
then email it to
vaxreporting@phila.gov
or fax to the contact above.
Complete in addition to the reporting agreement form to onboard more than 2 clinics.
Need help? Review the FAQ
The health department has recently identified a varicella (chickenpox) outbreak in a school and is sharing clinical reminders on the diagnosis and management of varicella. Varicella is a highly contagious disease that can be serious for non-immune pregnant people, newborns, and those with weak immune...
The vaccine distribution center will have reduced delivery capacity during the holiday season. Orders submitted during this time will take longer than usual to ship. November: Place your order by Friday, November 14, 2025, at 12 p.m. Orders placed after this date may not ship until December...
On September 18-19, 2025, CDC's Advisory Committee on Immunization Practices (ACIP) voted to recommend: MMRV (combined MMR + varicella) vaccine should not be given to children under 4 years old. It is recommended to administer MMR and varicella vaccines separately. Clinical Background: MMRV Vaccine The MMRV vaccine is a...
VFC providers can now order Moderna, Pfizer, & Sanofi 2025-2026 COVID-19 products for their eligible patients.Make sure that your EHR/EMR is set-up to report this year’s COVID-19 products.These are the vaccines available this year: *Pfizer 6 mos - 4 years is no longer available.**This is a...
On February 14, 2025, the Food and Drug Administration (FDA) approved GSK’s MenABCWY vaccine, Penmenvy, for use in individuals aged 10 through 25 years. Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) is now available through the Vaccines for Children (VFC) program. The vaccine is...
On June 9, 2025, the Food and Drug Administration (FDA) licensed Merck’s Enflonsia (clesrovimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI).On June 26, 2025, the Advisory Committee on Immunization Practices(ACIP) voted to recommend clesrovimab for use in infants younger than...
Vaccines for Children (VFC) providers are now welcome to order nirsevimab (Beyfortus) as needed. Nirsevimab (Beyfortus), a monoclonal antibody immunization used to prevent RSV infection in infants and young children, can be administered from October 1, 2025 to March 31, 2026. Once we receive your nirsevimab orders,...
The following products are now available to order: Flulaval (VFC & VFAAR) Fluzone (VFC only) Flucelvax (VFC only) FluMist (VFC only) 2025-2026 Available Influenza Products Vaccines for Children (VFC) Product Manufacture/NDC Eligibility Dose / Presentation / Type CPT Code CVX Code Available FluLaval GSK, 19515-0904-52 6 mos – 18 years 0.5 mL / Single-dose syringe / inactivated, trivalent 90656 140 Yes Fluzone Sanofi, 49281-0425-50 6 mos – 18...
As we prepare for the upcoming 2025-2026 season, our program would like to understand your practice's plans for offering COVID-19 vaccine to pediatric patients in light of recent CDC policy changes. Effective July 1, 2025, Vaccines for Children (VFC) providers are no longer required to order...
Join us for an informative virtual session on respiratory viruses. This session is for both primary care physicians (PCPs) and other vaccine providers to learn more about: respiratory syncytial virus (RSV) influenza COVID-19 vaccine ordering, storage, and administration information Infectious disease expert Dr. Mayssa Abuali will give an overview of...
All VFC & VFAAR influenza vaccine supplied by the Philadelphia Immunization Program during the 2024-2025 flu season has expired. Please account for unused VFC & VFAAR flu vaccine at your site using PhilaVax: Process a return for the unopened vials online in the Vaccines Returns module. A job aid with step by...
In the face of rapidly shifting vaccine policies and public uncertainty, it’s more important than ever for healthcare providers to be equipped with tools that foster trust and clarity around vaccination. We’ve developed strategies to support your conversations with patients—strategies that address misconceptions, center patient concerns,...
On May 29, 2025, the CDC updated the routine Child and Adolescent Immunization Schedule. All moderately and severely immunocompromised children should receive the COVID-19 vaccine. All other children may receive the COVID-19 vaccine based on shared decision-making between the patient/parent and the pediatrician, combining the...
Support Team Newsletter Spring 2025 Four Tips for Ordering Success 1. Complete all 3 steps on the same day: Email temperature data to tempcheck@phila.gov. Upload temperature data to Clinic Tools in PhilaVax.Learn how to upload temperature data. Complete your reconciliation on the same day!Learn how to complete a reconcilliation. 2. Order the right amount! When placing vaccine...
National Infant Immunization Week (NIIW) highlights the importance of protecting children two years and younger from vaccine-preventable diseases. Research consistently shows that healthcare professionals are the most trusted source of vaccine information for parents. Take this opportunity to speak about the importance of timely vaccination. Dr. Mayssa Abuali, Immunization Program Medical...
There is a growing number of measles cases in the United States. Most of these cases come from unvaccinated U.S. travelers who are infected with measles while traveling to other countries. Make sure your family and community know the risks of measles and how to...
It's Adolescent Immunization Action Week (AIAW)! Take action and access these resources. Adolescent Immunization Action Week (AIAW) reminds us to keep adolescents up-to-date on immunizations that protect against potentially life-threatening diseases like meningitis, tetanus, diphtheria, whooping cough, HPV-related cancers, COVID-19, and flu. Unity® Consortium offers digital and...
As the respiratory syncytial virus (RSV) season draws to a close on March 31, 2025, we want to remind all healthcare providers of essential considerations regarding administering the RSV immunization, nirsevimab (Beyfortus). End of RSV season: Continue to administer doses of nirsevimab to eligible children through March 31,...